Stock data
ANI Pharmaceuticals, Inc. (ANIP)
ANI Pharmaceuticals, Inc. (ANIP) reported revenue of US$883.37M and net income of US$78.34M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$883.37M | — | US$111.09M | US$78.34M | — |
| 2024 | US$614.38M | — | US$0.58M | -US$18.52M | — |
| 2023 | US$486.82M | — | US$46.97M | US$18.78M | — |
| 2022 | US$316.38M | — | -US$35.28M | -US$47.90M | — |
| 2021 | US$216.14M | — | -US$39.79M | -US$42.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$266.04M | US$24.71M | — |
| 2026-03-31 | US$237.46M | US$29.49M | — |
| 2025-12-31 | US$247.06M | US$27.49M | — |
| 2025-09-30 | US$227.81M | US$26.62M | — |
| 2025-06-30 | US$211.37M | US$8.55M | — |
| 2025-03-31 | US$197.12M | US$15.68M | — |
| 2024-12-31 | US$190.57M | -US$10.28M | — |
| 2024-09-30 | US$148.33M | -US$24.17M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.